NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/modivcare-inc-lawsui ...

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the ModivCare class action lawsuit – captioned Kalera v. ModivCare, Inc., No. 25-cv-00306 (D. Colo.) – charges ModivCare, Inc. (NASDAQ: MODV) as well as certain of ModivCare's top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the ModivCare class action lawsuit, please provide your information here: https://www.rgrdlaw.com ...

Forward Looking Statements Certain statements contained in herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. The updated guidance discussed herein constitutes forward-looking statements. Such f ...

Core Viewpoint - ModivCare Inc. is facing a class action lawsuit due to allegations of false statements and concealment of information that negatively impacted the company's financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [3]. Group 1: Allegations and Financial Impact - The lawsuit claims that certain contracts in ModivCare's NEMT segment led to a deterioration in the company's free cash flow [3]. - It is alleged that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA [3]. - The company reportedly faced liquidity issues as a result of these factors, and the defendants' positive statements about the company's business were misleading [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as November 3, 2022, to September 15, 2024 [3]. - Shareholders who purchased shares during this period are encouraged to register for participation in the class action, with a deadline set for March 31, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure that companies engage in responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - ModivCare, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims related to misleading statements and insufficient liquidity impacting the company's financial performance [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that ModivCare made false or misleading statements regarding contract renegotiations and pricing accommodations, which negatively affected the company's adjusted EBITDA [2]. - It is alleged that ModivCare had insufficient liquidity during the class period, further exacerbating its financial challenges [2]. Group 2: Legal Process and Participation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased ModivCare securities during the class period to seek appointment as lead plaintiff in the lawsuit [3]. - The lead plaintiff is expected to have the greatest financial interest in the case and will represent the interests of all class members [3]. Group 3: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud cases, having secured over $6.6 billion for investors in related class action cases [4]. - The firm has been recognized for its significant recoveries, including the largest securities class action recovery in history amounting to $7.2 billion in the Enron case [4].

Core Viewpoint - A class action securities lawsuit has been filed against ModivCare Inc. for alleged securities fraud affecting investors between November 3, 2022, and September 15, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that ModivCare made false statements and concealed information regarding contracts in its Non-Emergency Medical Transportation (NEMT) segment, which led to a deterioration in free cash flow [2]. - Allegations include that contract renegotiations and pricing accommodations negatively impacted the company's adjusted EBITDA, resulted in insufficient liquidity, and that positive statements about the company's business were materially misleading [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action lawsuit has been filed against ModivCare Inc. for alleged violations of securities laws, specifically related to misleading statements about the company's financial performance and liquidity issues [1][4]. Group 1: Lawsuit Details - The lawsuit pertains to ModivCare's actions between November 3, 2022, and September 15, 2024, during which investors are encouraged to participate if they suffered losses [2]. - The complaint alleges that ModivCare made false and misleading statements regarding its pricing accommodations and contract renegotiations, which adversely affected its adjusted EBITDA [4]. - The company is accused of failing to maintain sufficient liquidity, leading to materially misleading public statements throughout the class period [4]. Group 2: Investor Participation - Investors who purchased ModivCare's securities during the specified class period are urged to contact the Schall Law Firm before March 31, 2025, to discuss their rights [2][3]. - The class has not yet been certified, meaning that potential participants are not currently represented by an attorney unless they take action [3].

Core Viewpoint - ModivCare, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims related to misleading statements and insufficient liquidity impacting the company's financial performance [1][3]. Company Overview - ModivCare is a technology-enabled healthcare services company that offers integrated supportive care solutions for both public and private payors and their members [3]. Allegations - The lawsuit claims that during the Class Period, ModivCare made false or misleading statements and failed to disclose critical information, specifically that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA and that ModivCare had insufficient liquidity [3]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased ModivCare securities during the class period to seek appointment as lead plaintiff in the lawsuit. The lead plaintiff represents the interests of all class members and can choose a law firm for litigation [4].

Core Viewpoint - ModivCare Inc. is facing allegations of making false statements and concealing information that negatively impacted its financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that certain contracts in ModivCare's NEMT segment caused a deterioration in the company's free cash flow [1]. - As a result of these issues, the company experienced negative impacts on its adjusted EBITDA due to contract renegotiations and pricing accommodations [1]. - The company was reported to have insufficient liquidity, and the defendants' positive statements regarding the company's business and prospects were deemed materially misleading [1]. Group 2: Class Action Details - The class period for the allegations is from November 3, 2022, to September 15, 2024 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for March 31, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2].

Core Viewpoint - ModivCare, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims related to misleading statements and insufficient liquidity impacting the company's financial performance [1][3]. Company Overview - ModivCare is a technology-enabled healthcare services company that offers integrated supportive care solutions for both public and private payors and their members [3]. Allegations - The lawsuit claims that ModivCare's executives made false or misleading statements and failed to disclose critical information, specifically that contract renegotiations and pricing accommodations adversely affected the company's adjusted EBITDA and that ModivCare had insufficient liquidity [3]. Legal Process - Investors who purchased ModivCare securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [4]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud cases, having recovered $6.6 billion for investors in such cases, significantly more than any other firm in the last four years [5].